NCT06567093 Effect of Leg and Heel Massage on Pain During Heel Blood Collection Newborns
| NCT ID | NCT06567093 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bartın Unıversity |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-08-15 |
| Primary Completion | 2025-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-08-15 with a primary completion date of 2025-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was planned to evaluate the effect of leg and heel massage on newborns, the pain experienced during heel blood collection, and the effects on physiological parameters. H1: Newborn Infants Pain Scale scores are lower in leg and heel massage group than control group. H2: Heart rates are lower in leg and heel massage group than control group. H3: Oxygen saturation levels are higher in leg and heel massage group than control group.
Eligibility Criteria
Inclusion Criteria: * Gestational age is 38-41 weeks, * The birth weight of the newborn is \>2500 g * Vital signs should be stable before the procedure, * Postanatal age is between 2-28 days, * There are no contraindications for the application of massage * Delivery of the newborn to the mother after birth * Permission of the parents of the newborn participating in the research * Fasting period less than 3 hours/fed 30 minutes before * A newborn who does not cry before heel blood is taken Exclusion Criteria: * Newborns who need respiratory support, * Newborns with any neurological disorders (seizures) * Newborns using opioids or babies born to mothers using opioids * Newborns taking muscle relaxants, sedatives, analgesics * Babies with major congenital anomalies * Babies with an APGAR score of less than 7 in 5 minutes, * Newborns who have undergone any surgery * Newborns with birth trauma (especially rapid births) * There are situations that may prevent communication with parents (e.g. language problems). * problem) * Newborns planned to be transferred to another hospital
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06567093 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 28 Days, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06567093 currently recruiting?
Yes, NCT06567093 is actively recruiting participants. Contact the research team at aylinkurt67@gmail.com for enrollment information.
Where is the NCT06567093 trial being conducted?
This trial is being conducted at Bartın, Turkey (Türkiye).
Who is sponsoring the NCT06567093 clinical trial?
NCT06567093 is sponsored by Bartın Unıversity. The trial plans to enroll 60 participants.